Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hak Choy

Showing results (81-90 of 140) with videos related to

Pageof 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 24, 2012
Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology groupNatalie L Ausborn, Quynh Thu Le, Jeffrey D Bradley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 22, 2014
EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324Ritsuko Komaki, Rebecca Paulus, George R Blumenschein, et al.
JAMA|March 18, 2010
Stereotactic body radiation therapy for inoperable early stage lung cancerRobert Timmerman, Rebecca Paulus, James Galvin, et al.
Clinical Lung Cancer|December 17, 2008
Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancerHeather Wakelee, Kemp Kernstine, Everett Vokes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancerRobert Mutter, Bo Lu, David P Carbone, et al.
The Lancet. Oncology|March 20, 2019
Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort studyOsama Mohamad, Takahiro Tabuchi, Yuki Nitta, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancerAaron H Wolfson, Kyounghwa Bae, Ritsuko Komaki, et al.
Plos One|October 12, 2018
Accurate real time localization tracking in a clinical environment using Bluetooth Low Energy and deep learningZohaib Iqbal, Da Luo, Peter Henry, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Erratum. A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG N0927)Gregory M M Videtic, Chen Hu, Anurag K Singh, et al.
European Urology|April 25, 2006
Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse modelLance Walsh, Jennifer L Stanfield, L Chinsoo Cho, et al.
Pageof 14

Showing results (81-90 of 140) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|April 24, 2012
Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology groupNatalie L Ausborn, Quynh Thu Le, Jeffrey D Bradley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 22, 2014
EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324Ritsuko Komaki, Rebecca Paulus, George R Blumenschein, et al.
JAMA|March 18, 2010
Stereotactic body radiation therapy for inoperable early stage lung cancerRobert Timmerman, Rebecca Paulus, James Galvin, et al.
Clinical Lung Cancer|December 17, 2008
Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancerHeather Wakelee, Kemp Kernstine, Everett Vokes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancerRobert Mutter, Bo Lu, David P Carbone, et al.
The Lancet. Oncology|March 20, 2019
Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort studyOsama Mohamad, Takahiro Tabuchi, Yuki Nitta, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancerAaron H Wolfson, Kyounghwa Bae, Ritsuko Komaki, et al.
Plos One|October 12, 2018
Accurate real time localization tracking in a clinical environment using Bluetooth Low Energy and deep learningZohaib Iqbal, Da Luo, Peter Henry, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Erratum. A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG N0927)Gregory M M Videtic, Chen Hu, Anurag K Singh, et al.
European Urology|April 25, 2006
Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse modelLance Walsh, Jennifer L Stanfield, L Chinsoo Cho, et al.
Pageof 14